To demonstrate the utility of our technology in cancer research and the ability to co-express mutant or native proteins with amiR elements, in our cloning platform, we created an SB transposon armed to silence the endogenous Tp53 and overexpress an oncogenic hRas variant. The gene discussed is HRAS; the disease is cancer.